Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tecfidera
Tecfidera
Biogen Idec Inc.: Tecfidera Continues Its Blistering Pace
Motley Fool
Fri, 02/7/14 - 09:47 am
Tecfidera
Biogen Idec
MS
multiple sclerosis
Biogen's TECFIDERA approved in the European Union
Yahoo/Fly on the Wall
Mon, 02/3/14 - 09:30 am
Biogen
Tecfidera
Europe
MS
multiple sclerosis
Analysis of FDA side-effect reports flags Sanofi, Celgene meds
Fierce Pharma
Tue, 01/28/14 - 11:37 am
Celegene
FDA
Sanofi
side effects
Pomalyst
Tecfidera
Biogen Idec
Aubagio
Biogen's Tecfidera Time-Out Pays Off
Motley Fool
Tue, 11/26/13 - 04:38 pm
Tecfidera
Biogen Idec
MS
multiple sclerosis
Biogen wins protection for MS drug Tecfidera in Europe
Yahoo/Reuters
Fri, 11/22/13 - 09:01 am
Biogen Idec
MS
multiple sclerosis
Europe
Tecfidera
Tecfidera Succeeds in Protecting Biogen's MS Market Share From Novartis' Gilenya
Motley Fool
Sun, 11/3/13 - 12:12 pm
Gilenya
Novartis
MS
multiple sclerosis
Biogen Idec
Tecfidera
Novartis' Pharmaceutical Business Faces 2 Major Challenges
Motley Fool
Fri, 10/25/13 - 09:41 am
Novartis
Gilenya
Tecfidera
GSK
Seebri Breezhaler
COPD
Xolair
7 Disruptive Drugs for the Next Decade
Motley Fool
Wed, 10/9/13 - 10:42 pm
Tecfidera
Biogen Idec
Bristol-Myers Squibb
Eliquis
Pfizer
Roche
Kadcyla
Immunogen
sofosbuvir
Gilead
ibrutinib
Pharmacyclics
Sarepta
eteplirsen
LX4211
Lexicon Pharmaceuticals
Experts thinks Biogen to likely be able to market Tecfidera in EU, says Leerink
Yahoo/Fly on the Wall
Mon, 10/7/13 - 11:01 am
Biogen Idec
multiple sclerosis
MS
Europe
Tecfidera
Biogen's new MS drug maintains efficacy long term -study
Yahoo/Reuters
Fri, 10/4/13 - 10:18 am
MS
multiple sclerosis
Biogen Idec
Tecfidera
Top 15 Drug Launch Superstars
Fierce Pharma
Thu, 10/3/13 - 10:35 am
drug launches
Eylea
Regeneron
Bayer
Tecfidera
Biogen Idec
Kalydeco
Vertex Pharmaceuticals
Kadcyla
Roche
Genentech
Victoza
Novo Nordisk
Gilenya
Novartis
Zytiga
JNJ
Yervoy
Bristol-Myers Squibb
Stribild
Gilead Sciences Xtandi
Medivation
Astellas
Afinitor
Amgen
Prolia
Stelara
Kyprolis
Xarelto
ONYX Pharmaceuticals
Biogen may be capturing 50% of new MS patients, says Cowen
Yahoo/Fly on the Wall
Fri, 09/6/13 - 08:58 am
MS
Biogen Idec
multiple sclerosis
Tecfidera
Biogen Multiple Sclerosis Drug May Become Blockbuster
investors.com
Sat, 08/24/13 - 11:38 am
Biogen Idec
MS
multiple sclerosis
Tecfidera
Multiple Sclerosis market to reach more than $18bn by 2018
Datamonitor Healthcare
Tue, 08/20/13 - 12:13 pm
MS
multiple sclerosis
Biogen Idec
Tecfidera
Biogen Gains A Leg Up In Fiercely Competitive MS Field
Seeking Alpha
Thu, 08/8/13 - 06:54 pm
BiogenIdec
MS
multiple sclerosis
Tecfidera
3 Biotech Favorites With Noteworthy Drug Data
Motley Fool
Mon, 07/29/13 - 03:05 pm
Alexion
Biogen Idec
Soliris
Celgene
Revlimid
Tecfidera
Can Biogen Keep The Party Going After A Flawless Drug Launch? Comment Now Follow Comments
Forbes
Thu, 07/25/13 - 09:49 am
drug launches
Biogen Idec
Tecfidera
MS
multiple sclerosis
A Look at Four Major Players in Multiple Sclerosis Treatments
Motley Fool
Wed, 07/24/13 - 12:55 pm
MS
multiple sclerosis
XenoPort
BiogenIdec
Novartis
Alkermes
Tecfidera
Gilenya
ALKS 7106
Biogen shares slip on MS patient death, company says no connection
Marketwatch
Wed, 07/24/13 - 09:56 am
Biogen Idec
MS
multiple sclerosis
Tecfidera
Alkermes Adds Multiple Sclerosis Pill To Expanding Pipeline
TheStreet.com
Thu, 07/18/13 - 09:55 am
Alkermes
multiple sclerosis
MS
monomethyl fumarate
Tecfidera
BiogenIdec
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »